by The global dermatology diagnostic devices and therapeutics market size accounted for US$ 17.65 Bn in 2022 and is projected to reach around USD 34.9 Bn by 2030, growing at a CAGR of 8.89% from 2022 to 2030.
Report Summary
The global dermatology diagnostic devices and therapeutics market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the dermatology diagnostic devices and therapeutics market across the globe.
A comprehensive estimate on the dermatology diagnostic devices and therapeutics market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of dermatology diagnostic devices and therapeutics during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2409
Dermatology Diagnostic Devices and Therapeutics Market Report Scope
| Report Coverage | Details | ||||||||||||||||||
| Market Size in 2022 | USD 17.65 Billion | ||||||||||||||||||
| Market Size by 2030 | USD 34.9 Billion | ||||||||||||||||||
| Growth Rate from 2022 to 2030 | CAGR of 8.89% | ||||||||||||||||||
| Largest Market | North America | ||||||||||||||||||
| Fastest Growing Market | Asia Pacific | ||||||||||||||||||
| Base Year | 2021 | ||||||||||||||||||
| Forecast Period | 2022 to 2030 | ||||||||||||||||||
| Segments Covered |
|
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized dermatology diagnostic devices and therapeutics market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: U.S. Digital Therapeutics Market Size To Cross USD 12.09 Bn By 2030
Dermatology Diagnostic Devices and Therapeutics Market Players
The report includes the profiles of key dermatology diagnostic devices and therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- Canfield Scientific, Inc.
- Novartis International AG
- Valeant Pharmaceuticals International, Inc.
- gfa-Gevaert N.V.
- Galderma S.A.
- Michelson Diagnostics Ltd.
- Cutera, Inc.
- Astellas Pharma, Inc.
- Genentech
- GlaxoSmithKline plc
- LEO Pharma A/S
- Dino-Lite Europe/IDCP B.V.
Market Segmentation
By Diagnostic Devices
- Dermatoscopes
- Microscopes and Trichoscopes
- Imaging Equipment
By Application Class
- Diagnostic Devices
- Skin Cancer Diagnosis
- Other
- Treatment Devices
- Hair Removal
- Skin Rejuvenation
- Acne, Psoriasis, and Tattoo Removal
- Wrinkle Removal and Skin Resurfacing
- Body Contouring and Fat Removal
- Cellulite Reduction
- Vascular and Pigmented Lesion Removal
- Others
By End Use
- Hospitals
- Clinics
- Others
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Dermatology Diagnostic Devices And Therapeutics Market
5.1. COVID-19 Landscape: Dermatology Diagnostic Devices And Therapeutics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Dermatology Diagnostic Devices And Therapeutics Market, By Diagnostic Devices
8.1. Dermatology Diagnostic Devices And Therapeutics Market, by Diagnostic Devices, 2022-2030
8.1.1 Dermatoscopes
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Microscopes and Trichoscopes
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Imaging Equipment
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Dermatology Diagnostic Devices And Therapeutics Market, By Application Class
9.1. Dermatology Diagnostic Devices And Therapeutics Market, by Application Class, 2022-2030
9.1.1. Diagnostic Devices
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Treatment Devices
Chapter 10. Global Dermatology Diagnostic Devices And Therapeutics Market, By End Use
10.1. Dermatology Diagnostic Devices And Therapeutics Market, by End Use, 2022-2030
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Clinics
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Others
Chapter 11. Global Dermatology Diagnostic Devices And Therapeutics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.1.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.1.3. Market Revenue and Forecast, by End Use (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.1.4.3. Market Revenue and Forecast, by End Use (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.1.5.3. Market Revenue and Forecast, by End Use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.2.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.2.3. Market Revenue and Forecast, by End Use (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.2.4.3. Market Revenue and Forecast, by End Use (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.2.5.3. Market Revenue and Forecast, by End Use (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.2.6.3. Market Revenue and Forecast, by End Use (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.2.7.3. Market Revenue and Forecast, by End Use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.3.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.3.3. Market Revenue and Forecast, by End Use (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.3.4.3. Market Revenue and Forecast, by End Use (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.3.5.3. Market Revenue and Forecast, by End Use (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.3.6.3. Market Revenue and Forecast, by End Use (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.3.7.3. Market Revenue and Forecast, by End Use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.4.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.4.3. Market Revenue and Forecast, by End Use (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.4.4.3. Market Revenue and Forecast, by End Use (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.4.5.3. Market Revenue and Forecast, by End Use (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.4.6.3. Market Revenue and Forecast, by End Use (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.4.7.3. Market Revenue and Forecast, by End Use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.5.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.5.3. Market Revenue and Forecast, by End Use (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.5.4.3. Market Revenue and Forecast, by End Use (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Diagnostic Devices (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application Class (2017-2030)
11.5.5.3. Market Revenue and Forecast, by End Use (2017-2030)
Chapter 12. Company Profiles
12.1. Canfield Scientific, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Novartis International AG
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Valeant Pharmaceuticals International, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. gfa-Gevaert N.V.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Galderma S.A.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Michelson Diagnostics Ltd.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cutera, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Astellas Pharma, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Genentech
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. GlaxoSmithKline plc
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
